Isabel González-Gascón-y-Marín

Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study

Julio García‐Suárez, Javier de la Cruz, Ángel Cedillo et al. · Journal of Hematology & Oncology · 2020 · 238 citations · Full text

Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis <scp>B</scp> virus in patients with inflammatory bowel disease

Javier P. Gisbert, Luís Menchén, Valle García-Sánchez et al. · Alimentary Pharmacology & Therapeutics · 2012 · 91 citations · Full text

A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia

Isabel González-Gascón-y-Marín, María Hernández‐Sánchez, Ana‐Eugenia Rodríguez‐Vicente et al. · Hematological Oncology · 2015 · 30 citations

A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia

José‐Ángel Hernández‐Rivas, María Hernández‐Sánchez, Ana E. Rodríguez‐Vicente et al. · PLoS ONE · 2015 · 26 citations · Full text

Chronic Lymphocytic Leukemia, Cytogenetics, Genetics +19

The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index

Carolina Muñoz‐Novas, María Poza-Santaella, Isabel González-Gascón-y-Marín et al. · BioMed Research International · 2018 · 23 citations · Full text